Indication
Genital herpes simplex
Genital herpes simplex is a common sexually transmitted infection of the anogenital skin and mucosa caused by herpes simplex virus type 2 (HSV-2) or herpes simplex virus type 1 (HSV-1). Read more about Genital herpes simplex
112 drugs 87 manufacturers
Drugs that treat it
Common Genital herpes simplex therapies.
VALACYCLOVIR (valacyclovir HCl)
VALACYCLOVIR (valacyclovir HCl)
ACYCLOVIR
ACYCLOVIR
VALACYCLOVIR (valacyclovir HCl)
ACYCLOVIR SODIUM
ZOVIRAX (acyclovir)
ACYCLOVIR
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGenital herpes simplex is a common sexually transmitted infection of the anogenital skin and mucosa caused by herpes simplex virus type 2 (HSV-2) or herpes simplex virus type 1 (HSV-1).
Pathophysiologically, the virus establishes lifelong latency within the sacral sensory nerve ganglia following primary inoculation, intermittently reactivating to cause recurrent episodes or asymptomatic viral shedding.
Clinical manifestations range from asymptomatic infection to outbreaks characterized by localized paresthesias, erythema, and clusters of painful vesicles that ulcerate, crust, and heal, frequently accompanied by regional lymphadenopathy, dysuria, and systemic symptoms during initial episodes.
- medlineplus.gov
Genital herpes simplex is a common sexually transmitted infection of the anogenital skin and mucosa caused by herpes simplex virus type 2 (HSV-2) or herpes simplex virus type 1 (HSV-1) Pathophysiologically, the virus establishes lifelong latency within the sacral sensory nerve ganglia following primary inoculation, intermittently reactivating to cause recurrent episodes or asymptomatic viral shedding
- nih.gov
Genital herpes simplex is a common sexually transmitted infection of the anogenital skin and mucosa caused by herpes simplex virus type 2 (HSV-2) or herpes simplex virus type 1 (HSV-1)
- nih.gov
Pathophysiologically, the virus establishes lifelong latency within the sacral sensory nerve ganglia following primary inoculation, intermittently reactivating to cause recurrent episodes or asymptomatic viral shedding
- medlineplus.gov
Clinical manifestations range from asymptomatic infection to outbreaks characterized by localized paresthesias, erythema, and clusters of painful vesicles that ulcerate, crust, and heal, frequently accompanied by regional lymphadenopathy, dysuria, and systemic symptoms during initial episodes
- mayoclinic.org
Clinical manifestations range from asymptomatic infection to outbreaks characterized by localized paresthesias, erythema, and clusters of painful vesicles that ulcerate, crust, and heal, frequently accompanied by regional lymphadenopathy, dysuria, and systemic symptoms during initial episodes
Personalize your experience
Follow Genital herpes simplex and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.